Microenvironment-responsive nanocarriers for targeted bone disease therapy
M Li, B Yu, S Wang, F Zhou, J Cui, J Su - Nano Today, 2023 - Elsevier
Nanomedicines with controlled drug release have received increasing attention as an
advanced therapeutic strategy for bone diseases. To traverse biological barriers towards …
advanced therapeutic strategy for bone diseases. To traverse biological barriers towards …
Tumour targeting with radiometals for diagnosis and therapy
CF Ramogida, C Orvig - Chemical Communications, 2013 - pubs.rsc.org
Use of radiometals in nuclear oncology is a rapidly growing field and encompasses a broad
spectrum of radiotracers for imaging via PET (positron emission tomography) or SPECT …
spectrum of radiotracers for imaging via PET (positron emission tomography) or SPECT …
Targeted dual-contrast T1-and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide …
Abstract Development of a multifunctional nanoparticle (NP) system allowing for dual-
contrast T 1-and T 2-weighted targeted magnetic resonance (MR) imaging of tumors could …
contrast T 1-and T 2-weighted targeted magnetic resonance (MR) imaging of tumors could …
[HTML][HTML] Roles of focal adhesion proteins in skeleton and diseases
The skeletal system, which contains bones, joints, tendons, ligaments and other elements,
plays a wide variety of roles in body shaping, support and movement, protection of internal …
plays a wide variety of roles in body shaping, support and movement, protection of internal …
Bone development: overview of bone cells and signaling
A Teti - Current osteoporosis reports, 2011 - Springer
Vertebrates evolved elaborating a structure made up of more than 200 bones and cartilages
articulated with one another to form the skeleton, through which locomotion, organ …
articulated with one another to form the skeleton, through which locomotion, organ …
Positron emission tomography tracers for imaging angiogenesis
Position emission tomography imaging of angiogenesis may provide non-invasive insights
into the corresponding molecular processes and may be applied for individualized treatment …
into the corresponding molecular processes and may be applied for individualized treatment …
Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology
GJR Cook, G Azad, AR Padhani - Clinical and translational imaging, 2016 - Springer
The bone scan continues to be recommended for both the staging and therapy response
assessment of skeletal metastases from prostate cancer. However, it is widely recognised …
assessment of skeletal metastases from prostate cancer. However, it is widely recognised …
A targeted and pH-responsive bortezomib nanomedicine in the treatment of metastatic bone tumors
Bortezomib is a boronate proteasome inhibitor widely used as an efficient anticancer drug;
however, the clinical use of bortezomib is hampered by its adverse effects such as …
however, the clinical use of bortezomib is hampered by its adverse effects such as …
High tumor uptake of 64Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers
JT Jørgensen, M Persson, J Madsen, A Kjær - Nuclear medicine and …, 2013 - Elsevier
INTRODUCTION: The use of copper-based positron emission tomography (PET) tracers in
cancer studies is increasing. However, as copper has previously been found in high …
cancer studies is increasing. However, as copper has previously been found in high …
Measurement of the rate of copper (II) exchange for 64Cu complexes of bifunctional chelators
V Maheshwari, JLJ Dearling, ST Treves… - Inorganica Chimica …, 2012 - Elsevier
Measurement of the rate of loss of 64Cu from the chelators used in the preparation of 64Cu-
labeled proteins is critical to the development of effective 64Cu-labeled …
labeled proteins is critical to the development of effective 64Cu-labeled …